Davies NM - Search Results

1

CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.

Zhao Y, Zhang T, Duan S, Davies NM, Forrest ML. Zhao Y, et al. Among authors: davies nm. Nanomedicine. 2014 Aug;10(6):1221-30. doi: 10.1016/j.nano.2014.02.015. Epub 2014 Mar 15. Nanomedicine. 2014. PMID: 24637218 Free PMC article.

2

Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin.

Yáñez JA, Forrest ML, Ohgami Y, Kwon GS, Davies NM. Yáñez JA, et al. Among authors: davies nm. Cancer Chemother Pharmacol. 2008 Jan;61(1):133-44. doi: 10.1007/s00280-007-0458-z. Epub 2007 Mar 29. Cancer Chemother Pharmacol. 2008. PMID: 17393166 Free PMC article.

3

Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery.

Xiong MP, Forrest ML, Ton G, Zhao A, Davies NM, Kwon GS. Xiong MP, et al. Among authors: davies nm. Biomaterials. 2007 Nov;28(32):4889-900. doi: 10.1016/j.biomaterials.2007.07.043. Epub 2007 Aug 10. Biomaterials. 2007. PMID: 17692910

4

Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.

Forrest ML, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM. Forrest ML, et al. Among authors: davies nm. Pharm Res. 2008 Jan;25(1):194-206. doi: 10.1007/s11095-007-9451-9. Epub 2007 Oct 3. Pharm Res. 2008. PMID: 17912488 Free PMC article.

5

Clinical toxicities of nanocarrier systems.

Vega-Villa KR, Takemoto JK, Yáñez JA, Remsberg CM, Forrest ML, Davies NM. Vega-Villa KR, et al. Among authors: davies nm. Adv Drug Deliv Rev. 2008 May 22;60(8):929-38. doi: 10.1016/j.addr.2007.11.007. Epub 2008 Feb 7. Adv Drug Deliv Rev. 2008. PMID: 18313790 Review.

6

Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats.

Xiong MP, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM, Forrest ML. Xiong MP, et al. Among authors: davies nm. J Control Release. 2008 Jul 2;129(1):33-40. doi: 10.1016/j.jconrel.2008.03.015. Epub 2008 Mar 25. J Control Release. 2008. PMID: 18456363 Free PMC article.

7

A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.

Xiong MP, Yáñez JA, Kwon GS, Davies NM, Forrest ML. Xiong MP, et al. Among authors: davies nm. J Pharm Sci. 2009 Apr;98(4):1577-86. doi: 10.1002/jps.21509. J Pharm Sci. 2009. PMID: 18752263 Free PMC article.

8

Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents.

Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Cai S, et al. Among authors: davies nm. J Pharm Sci. 2010 Jun;99(6):2664-71. doi: 10.1002/jps.22016. J Pharm Sci. 2010. PMID: 19960530 Free PMC article.

9

Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.

Xie Y, Aillon KL, Cai S, Christian JM, Davies NM, Berkland CJ, Forrest ML. Xie Y, et al. Among authors: davies nm. Int J Pharm. 2010 Jun 15;392(1-2):156-63. doi: 10.1016/j.ijpharm.2010.03.058. Epub 2010 Apr 2. Int J Pharm. 2010. PMID: 20363303 Free PMC article.

10

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.

Cai S, Thati S, Bagby TR, Diab HM, Davies NM, Cohen MS, Forrest ML. Cai S, et al. Among authors: davies nm. J Control Release. 2010 Sep 1;146(2):212-8. doi: 10.1016/j.jconrel.2010.04.006. Epub 2010 Apr 18. J Control Release. 2010. PMID: 20403395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters